Patients with PFTK1(+) tumours (n=115) showed significantly poorer OS and RFS than those with PFTK1(−) tumours (n=108) (5-year OS: 43.6% vs 66.2%, P<0.001, 5-year RFS; 41.4% vs 62.8%, P=0.001, Figure 3). Here, CDK14 is linked to neoplasm.